Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2000 3
2001 3
2002 3
2003 2
2004 2
2005 3
2006 2
2007 1
2008 5
2009 7
2010 7
2011 8
2012 5
2013 3
2014 5
2015 7
2016 6
2017 6
2018 1
2019 2
2020 6
2021 3
2022 4
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Identification of the genetic mechanism that associates L3MBTL3 to multiple sclerosis.
Alcina A, Fedetz M, Vidal-Cobo I, Andrés-León E, García-Sánchez MI, Barroso-Del-Jesus A, Eichau S, Gil-Varea E, Luisa-Maria Villar, Saiz A, Leyva L, Vandenbroeck K, Otaegui D, Izquierdo G, Comabella M, Urcelay E, Matesanz F. Alcina A, et al. Among authors: leyva l. Hum Mol Genet. 2022 Jul 7;31(13):2155-2163. doi: 10.1093/hmg/ddac009. Hum Mol Genet. 2022. PMID: 35088080 Free PMC article.
Skin Phototype Could Be a Risk Factor for Multiple Sclerosis.
Urbaneja P, Hurtado-Guerrero I, Hernández MÁ, Oliver-Martos B, Oreja-Guevara C, Ortega-Pinazo J, Alonso A, Barón-López FJ, Leyva L, Fernández Ó, Pinto-Medel MJ. Urbaneja P, et al. Among authors: leyva l. J Clin Med. 2020 Jul 26;9(8):2384. doi: 10.3390/jcm9082384. J Clin Med. 2020. PMID: 32722577 Free PMC article.
Antiviral, Immunomodulatory and Antiproliferative Activities of Recombinant Soluble IFNAR2 without IFN-ß Mediation.
Hurtado-Guerrero I, Hernáez B, Pinto-Medel MJ, Calonge E, Rodriguez-Bada JL, Urbaneja P, Alonso A, Mena-Vázquez N, Aliaga P, Issazadeh-Navikas S, Pavia J, Leyva L, Alcamí J, Alcamí A, Fernández Ó, Oliver-Martos B. Hurtado-Guerrero I, et al. Among authors: leyva l. J Clin Med. 2020 Mar 31;9(4):959. doi: 10.3390/jcm9040959. J Clin Med. 2020. PMID: 32244308 Free PMC article.
Analysis of Plasminogen Genetic Variants in Multiple Sclerosis Patients.
Sadovnick AD, Traboulsee AL, Bernales CQ, Ross JP, Forwell AL, Yee IM, Guillot-Noel L, Fontaine B, Cournu-Rebeix I, Alcina A, Fedetz M, Izquierdo G, Matesanz F, Hilven K, Dubois B, Goris A, Astobiza I, Alloza I, Antigüedad A, Vandenbroeck K, Akkad DA, Aktas O, Blaschke P, Buttmann M, Chan A, Epplen JT, Gerdes LA, Kroner A, Kubisch C, Kümpfel T, Lohse P, Rieckmann P, Zettl UK, Zipp F, Bertram L, Lill CM, Fernandez O, Urbaneja P, Leyva L, Alvarez-Cermeño JC, Arroyo R, Garagorri AM, García-Martínez A, Villar LM, Urcelay E, Malhotra S, Montalban X, Comabella M, Berger T, Fazekas F, Reindl M, Schmied MC, Zimprich A, Vilariño-Güell C. Sadovnick AD, et al. Among authors: leyva l. G3 (Bethesda). 2016 Jul 7;6(7):2073-9. doi: 10.1534/g3.116.030841. G3 (Bethesda). 2016. PMID: 27194806 Free PMC article.
Technical challenges for complete implementation of automated growth-based methods for microbiological examination of advanced therapy medicinal products. What's wrong with Candida albicans?
Rodríguez-Acosta A, Chaparro-García J, De-Toro I, Maldonado-Sánchez R, Muñoz-Fernández R, Antúnez C, Frecha C, Leyva L. Rodríguez-Acosta A, et al. Among authors: leyva l. Cytotherapy. 2022 Mar;24(3):320-333. doi: 10.1016/j.jcyt.2021.11.002. Epub 2022 Jan 13. Cytotherapy. 2022. PMID: 35033424 Free article.
Early development of anti-natalizumab antibodies in MS patients.
Oliver-Martos B, Órpez-Zafra T, Urbaneja P, Maldonado-Sanchez R, Leyva L, Fernández O. Oliver-Martos B, et al. Among authors: leyva l. J Neurol. 2013 Sep;260(9):2343-7. doi: 10.1007/s00415-013-6991-2. Epub 2013 Jun 14. J Neurol. 2013. PMID: 23765090 Clinical Trial.
83 results